Emi Minejima, PharmD

Title(s)Associate Professor of Clinical Pharmacy
SchoolUSC School of Pharmacy
AddressPSC B15-B
Health Sciences Campus
Los Angeles CA 90089-9121
Phone+1 323 442 1437
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Dr. Minejima joined the faculty at the University of Southern California School of Pharmacy in August 2012 as Assistant Professor of Clinical Pharmacy. She graduated from University of California-Berkeley with a BS in molecular and cell biology (2005) and from University of California-San Diego School of Pharmacy (2009). Dr. Minejima completed her postgraduate residency training in pharmacy practice and infectious disease at Huntington Hospital in Pasadena.

    Her clinical practice is based at LAC+USC Medical Center where she focuses on the antimicrobial stewardship program, research and precepting pharmacy students and residents in acute care medicine and infectious disease clerkships.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Cytokine measurements add value to clinical variables in predicting outcomes for Staphylococcus aureus bacteremia. BMC Infect Dis. 2021 Apr 05; 21(1):317. Tan K, Minejima E, Lou M, Mack WJ, Nieberg P, Wong-Beringer A. PMID: 33820537; PMCID: PMC8022397.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    2. Distance Between Home and the Admitting Hospital and Its Effect on Survival of Low Socioeconomic Status Population With Staphylococcus aureus Bacteremia. Public Health Rep. 2022 Jan-Feb; 137(1):110-119. Minejima E, Wang J, Boettcher S, Liu L, Lou M, She RC, Wenzel SL, Spellberg B, Wong-Beringer A. PMID: 33715536; PMCID: PMC8721749.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    3. Impact of Socioeconomic Status and Race on Sepsis Epidemiology and Outcomes. J Appl Lab Med. 2021 01 12; 6(1):194-209. Minejima E, Wong-Beringer A. PMID: 33241269.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    4. Cost-benefit analysis comparing trough, two-level AUC and Bayesian AUC dosing for vancomycin. Clin Microbiol Infect. 2021 Sep; 27(9):1346.e1-1346.e7. Lee BV, Fong G, Bolaris M, Neely M, Minejima E, Kang A, Lee G, Gong CL. PMID: 33221430.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    5. Defining the Breakpoint Duration of Staphylococcus aureus Bacteremia Predictive of Poor Outcomes. Clin Infect Dis. 2020 02 03; 70(4):566-573. Minejima E, Mai N, Bui N, Mert M, Mack WJ, She RC, Nieberg P, Spellberg B, Wong-Beringer A. PMID: 30949675; PMCID: PMC7768749.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansCells
    6. Don't Get Wound Up: Revised Fluoroquinolone Breakpoints for Enterobacteriaceae and Pseudomonas aeruginosa. J Clin Microbiol. 2019 07; 57(7). Van TT, Minejima E, Chiu CA, Butler-Wu SM. PMID: 31043468; PMCID: PMC6595448.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    7. Utility of qSOFA score in identifying patients at risk for poor outcome in Staphylococcus aureus bacteremia. BMC Infect Dis. 2019 Feb 13; 19(1):149. Minejima E, Delayo V, Lou M, Ny P, Nieberg P, She RC, Wong-Beringer A. PMID: 30760213; PMCID: PMC6375176.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    8. Expected Practice as a Novel Antibiotic Stewardship Intervention. Open Forum Infect Dis. 2019 Jan; 6(1):ofy319. Yadav K, Masuda E, Minejima E, Spellberg B. PMID: 30631789; PMCID: PMC6324551.
      View in: PubMed   Mentions: 5  
    9. Prospective Trial on the Use of Trough Concentration versus Area under the Curve To Determine Therapeutic Vancomycin Dosing. Antimicrob Agents Chemother. 2018 02; 62(2). Neely MN, Kato L, Youn G, Kraler L, Bayard D, van Guilder M, Schumitzky A, Yamada W, Jones B, Minejima E. PMID: 29203493; PMCID: PMC5786789.
      View in: PubMed   Mentions: 119     Fields:    Translation:HumansCellsCTClinical Trials
    10. Staphylococcus aureus Bacteremia in Patients not Meeting Sepsis Criteria: Clinical Features, Host Immune Response and Outcomes. J Clin Med Ther. 2017; 2(4). Salas DE, Minejima E, Wu J, Fang C, Wang J, She R, Nieberg P, Wong-Beringer A. PMID: 31058274; PMCID: PMC6497173.
      View in: PubMed   Mentions: 4  
    11. Implementation of rapid diagnostics with antimicrobial stewardship. Expert Rev Anti Infect Ther. 2016 11; 14(11):1065-1075. Minejima E, Wong-Beringer A. PMID: 27599796.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    12. A Dysregulated Balance of Proinflammatory and Anti-Inflammatory Host Cytokine Response Early During Therapy Predicts Persistence and Mortality in Staphylococcus aureus Bacteremia. Crit Care Med. 2016 Apr; 44(4):671-9. Minejima E, Bensman J, She RC, Mack WJ, Tuan Tran M, Ny P, Lou M, Yamaki J, Nieberg P, Ho J, Wong-Beringer A. PMID: 26540400; PMCID: PMC6504958.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCells
    13. Patients presenting to the hospital with MRSA pneumonia: differentiating characteristics and outcomes with empiric treatment. BMC Infect Dis. 2014 May 10; 14:252. Minejima E, Lou M, Nieberg P, Wong-Beringer A. PMID: 24885158; PMCID: PMC4018616.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    14. Applying new diagnostic criteria for acute kidney injury to facilitate early identification of nephrotoxicity in vancomycin-treated patients. Antimicrob Agents Chemother. 2011 Jul; 55(7):3278-83. Minejima E, Choi J, Beringer P, Lou M, Tse E, Wong-Beringer A. PMID: 21576448; PMCID: PMC3122454.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    Emi's Networks
    Concepts (70)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (8)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.

    This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.